QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online December 15, 2003
doi: 10.1242/10.1242/jcs.00850

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bhattacharya, G. Articles by Cosgrove, D. Search for Related Content PubMed PubMed Citation Articles by Bhattacharya, G. Articles by Cosgrove, D.

A domain-specific usherin/collagen IV interaction may be required for stable integration into the basement membrane superstructure

¹ Usher Syndrome Center, Boys Town National Research Hospital, 555 No. 30^th Street, Omaha, Nebraska, 68131, USA
² Program in Matrix Biology, Gastroenterology and Renal Divisions, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA

^* Author for correspondence (e-mail: cosgrove{at}boystown.org)

Accepted 1 September 2003

Usherin is a basement membrane protein encoded by the gene associated with Usher syndrome type IIa, the most common deaf/blind disorder. This report demonstrates a specific interaction between type IV collagen and usherin in the basement membrane, with a 1:1 stoichiometry for binding. Genetic and biochemical approaches were used to explore the role of type IV collagen binding in usherin function. We demonstrate binding occurs between the LE domain of usherin and the 7S domain of type IV collagen. A purified fusion peptide comprising the first four LE modules was shown to compete with full-length recombinant usherin for type IV collagen binding. However, synonymous fusion peptides with single amino acid substitutions resulting from missense mutations that were known to cause Usher syndrome type IIa in humans, failed to compete. Only mutations in loop b of the LE domain abolished binding activity. Co-immunoprecipitation and western blot analysis of testicular basement membranes from the Alport mouse model show a 70% reduction in type IV collagen is associated with a similar reduction in usherin, suggesting the usherin/collagen (IV) interaction stabilizes usherin in the basement membrane. Thus, the domain-specific interaction between usherin and type IV collagen appears essential to usherin stability in vivo, and loss of this interaction may result in Usher pathology in humans.

Key words: Usherin, Basement membrane, Collagen (IV), Usher syndrome, Protein interaction

This article has been cited by other articles:

				T. Takahashi, O. Yamada, M. J Soares, and K. Hashizume Bovine prolactin-related protein-I is anchored to the extracellular matrix through interactions with type IV collagen J. Endocrinol., February 1, 2008; 196(2): 225 - 234. [Abstract] [Full Text] [PDF]

				H. Kremer, E. van Wijk, T. Marker, U. Wolfrum, and R. Roepman Usher syndrome: molecular links of pathogenesis, proteins and pathways Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R262 - R270. [Abstract] [Full Text] [PDF]

				A. Adato, G. Lefevre, B. Delprat, V. Michel, N. Michalski, S. Chardenoux, D. Weil, A. El-Amraoui, and C. Petit Usherin, the defective protein in Usher syndrome type IIA, is likely to be a component of interstereocilia ankle links in the inner ear sensory cells Hum. Mol. Genet., December 15, 2005; 14(24): 3921 - 3932. [Abstract] [Full Text] [PDF]

				J. Reiners, E. van Wijk, T. Marker, U. Zimmermann, K. Jurgens, H. te Brinke, N. Overlack, R. Roepman, M. Knipper, H. Kremer, et al. Scaffold protein harmonin (USH1C) provides molecular links between Usher syndrome type 1 and type 2 Hum. Mol. Genet., December 15, 2005; 14(24): 3933 - 3943. [Abstract] [Full Text] [PDF]

				S. B. Schwartz, T. S. Aleman, A. V. Cideciyan, E. A. M. Windsor, A. Sumaroka, A. J. Roman, T. Rane, E. E. Smilko, J. Bennett, E. M. Stone, et al. Disease Expression in Usher Syndrome Caused by VLGR1 Gene Mutation (USH2C) and Comparison with USH2A Phenotype Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 734 - 743. [Abstract] [Full Text] [PDF]